Brief: Harrow Announces 52-Week Data From VEVYE ESSENCE-2 Open-Label Extension Study
05/06/2024 12:54
June 5 (Reuters) - Harrow Inc HROW.O :
* HARROW ANNOUNCES 52-WEEK DATA FROM VEVYE® ESSENCE-2
OPEN-LABEL
EXTENSION STUDY
Source text for Eikon: ID:nBwVwP0ba
Further company coverage: HROW.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Harrow
See all newsHarrow, Inc. reports results for the quarter ended June 30 - Earnings Summary
Harrow Q2 revenue slightly beats estimates
Viatris raises annual profit forecast on branded drug strength
Brief: Harrow Re-Launches Verkazia® (Cyclosporine Ophthalmic Emulsion) 0.1% For Vernal Keratoconjunctivitis, Addressing Significant Unmet Need In Pediatric Eyecare
Harrow Q1 revenue misses analyst estimates